November 13, 2024
Loading...
You are here:  Home  >  Banking & Finance  >  Current Article

Kleiner Perkins startup could spell new era for Amgen

IN THIS ARTICLE

In a sign that its pipeline strategy might be shifting, Thousand Oaks-based Amgen has paired up with one of the most prominent venture capital firms in Silicon Valley to start a new company to develop six of its drug ideas. Atara Biotherapeutics will be financed by Kleiner Perkins Caufield & Byers, which will retain a…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.